Booth 2108
Date
February 9-11, 2026
Location
Thomas Michael Menino Convention & Exhibition Center (MCEC)
Boston, MA
Stay tuned for more talks and posters.
| Time | Type | Description | Room / Location | Presenter |
| 8:30AM - 4:30 PM PST | Short Course | Mastering 3D Cell Culture: A Practical Toolbox from Research to High Throughput To 3D or not to 3D – this is a question at the forefront for most people in discovery programs. With the passing of the FDA Modernization Act 2.0, there is a greater interest in the community around the use of physiologically relevant in vitro models as New Approach Methods (NAM) for the use of IND enabling submissions to the FDA. This workshop is designed to help participants understand the nuts and bolts of setting up 3D physiologically relevant models will allow participants to understand not only the utility of these models in answering a specific biological question but also to understand the practical importance of the various stages of assay development, automation compatibility, high content imaging and data analysis. Without a robust, scalable and reproducibly functioning assay there is no actionable data. At the end of this workshop, participants should be able to leave with the confidence of understanding the importance of robust and scalable assay development for 3D models and how that will allow them to position and prioritize pre-clinical candidates in their discovery programs.
Molecular Devices. | Room 107B | Angeline Lim, PhD |
| Time | Type | Description | Room / Location | Presenter |
| 2:00 - 3:00 PM | Exhibitor Tutorial | Cytiva Exhibitor Tutorial Cracking complexity with confidence: Automated SPR workflows made simple
Cytiva. | Room 107B | Robyn Stoller |
| 2:00 - 3:00 PM | Exhibitor Tutorial | Cutting Days from the DMTA Cycle with Intelligent Data Workflows The DMTA cycle is central to drug discovery, yet data handling and analysis remain major sources of delay even as wet‑lab automation advances. This tutorial highlights how intelligent data workflows can eliminate these bottlenecks and significantly accelerate Drug discovery projects. We will show how Genedata Screener accelerates the DMTA cycle through vendor‑agnostic integrations, automated data capture, real‑time monitoring, and standardized reporting. AI‑driven capabilities (including automated curve classification, SPR analysis, and QC assessment) further reduce manual workload and ensure rapid, high‑quality insights at scale. Finally, we introduce our roadmap for Assay Cascade Management, extending these efficiencies across full discovery workflows. Together, these innovations demonstrate how automation and smart analytics can remove days from DMTA iterations and increase overall R&D productivity.
Genedata. | Room 104A | Alexandre Peter |
| 3:30 - 3:50 PM | Scientific Talks | Cytiva Solutions Spotflight Rapid characterization of nanobody-target interactions using Biacore™ cap-tag capture kit
Cytiva. | Exhibition Hall: Solutions Spotlight Theater | Silas Chan |
| 12:00- 12:20 PM | Poster | Beckman Coulter Life Sciences Solutions Spotlight
Beckman Coulter Life Sciences. | Ex Hall Theater Booth 34 |
| Time | Type | Description | Room / Location | Presenter |
| 12:00 - 1:15 PM | Exhibitor Tutorial | Connecting High-Throughput Organoid Workflows to Actionable Results Through AI-Driven Automated Cell Culture and Endpoint Analysis Drug development pipelines face high attrition rates, often due to the limited predictive power of traditional 2D cell models. Organoid technologies have emerged as a transformative solution, offering physiologically relevant structures and improved predictivity for drug response. However, scaling organoid culture and performing complex assays remain technical challenges that limit adoption in early-stage screening.
To address these challenges, we developed CellXpress.ai™, an AI-driven automated cell culture system that connects high-throughput organoid workflows to actionable results. This integrated platform automates organoid generation, maintenance, and assay execution using advanced robotics and machine-learning-driven process control. The system combines automated liquid handling, imaging, and incubation with intelligent scheduling and decision-making, enabling dynamic interventions such as passaging, assay initiation, and troubleshooting.
For endpoint analysis, HCS.ai and IN carta deliver advanced imaging and high-content analysis capabilities. These tools enable automated segmentation, phenotypic profiling, and extraction of functional metrics from complex 3D organoid models. Together, they provide deep insights into morphology, viability, and phenotypic changes—turning raw imaging data into actionable results.
We will showcase real-world examples of these connected workflows applied to iPSC-derived models, brain organoids, and patient-derived tumour organoids. These case studies demonstrate how automation and intelligent imaging improve reproducibility, reduce variability, and accelerate decision-making—bridging biology and technology for next-generation drug discovery.
Molecular Devices. | Room 104A | Aaron Risinger |
| 12:00 - 1:15 PM | Exhibitor Tutorial | SureFire and SimpleStep ELISA; High Sensitivity Screening Platforms Powered by Recombinant Antibody Technology In this talk, we’ll delve into the advantages of SimpleStep® ELISA technology, which combines the specificity of recombinant antibodies with the CaptSure immobilization technology. We’ll highlight innovation in high-throughput immunoassays, with a particular focus on SureFire® – the pharmaceutical industry’s go-to platform for high-throughput screening in drug discovery research – as well as a new 384-well format of SimpleStep ELISA. Finally, we’ll examine how our immunoassays effectively solve specific customer challenges, enhancing research efficiency and precision within the field.
Abcam. | Room 104C | Moein Mohammadi/Ant Sheehan |
| 12:00 - 1:15 PM | Exhibitor Tutorial | Meet the team behind the SCIEX Echo® MS+ system for drug discovery assays
SCIEX. | Room 106 | Andrew Wagner (BMS), Alandra Quinn (Phizer), Kean Woodmansey (SCIEX), and Nick Herold (SCIEX) |
| 2:00 - 3:00 PM | Scientific Talks | High Content Screening with Genedata Screener Image-based assays offer potentially deeper insights about candidate molecules, but their analyses can create a bottleneck, particularly when performed at higher throughput in the drug discovery process. In this spotlight presentation, we will show how to tackle such multiparametric analyses using Genedata Screener, an enterprise platform for assay data analysis and management. Using a deep learning-based analysis platform fully integrated with downstream analytics to streamline high-content screening analysis, Genedata Screener is automating the entire workflow, from instrument-agnostic data loading to automated reporting.
Genedata. | Room 104A | Devika Kishan |
| 12:00 - 1:15 PM | Scientific Talks | Beckman Coulter Life Sciences Tutorial
Beckman Coulter Life Sciences. | Room 103 | |
| 4:30 - 4:50 PM | Scientific Talks | Beckman Coulter Life Sciences Solutions Spotlight
Beckman Coulter Life Sciences. | Ex Hall Theater Booth 343 | |
| 2:00-3:00 PM | Posters | Competitive SimpleStep ELISA; A 90 min one-wash assay for the quantification of small molecules, PTMs, and peptides
Abcam. | Exhibit Hall | Eric Swanson |
| 1:00-2:00 PM | Topical Interest Group | TIG - Academic Drug Discovery Academic drug discovery is entering a transformative decade. AI-driven design, autonomous automation, and human-centric models—such as organoids and tissue chips—are redefining what’s possible. These advances promise speed and precision, but they also raise critical questions: What will still need human insight in 10 years? How do we prepare the next generation of scientists? This session explores the proliferation of automation platforms and the shift from isolated robotic arms to fully integrated, self-driving workflows capable of running complex organoid assays and multi-omics pipelines. We’ll examine how data integration—linking imaging, phenotypic screens, and omics—creates richer insights for AI, and why AI-ready data is about more than size. It requires FAIR principles, robust quality controls, clear provenance, and even negative results to build trust. We’ll highlight NIH’s push for human-relevant models and standardized organoid protocols, and discuss how academia can lead translational efforts while training students for a world where biology, automation, and data science intersect. Finally, we’ll ask: Is this a paradise of creativity and collaboration—or a pitfall of black-box systems and irreproducible data? Join us for a lively discussion and a practical roadmap for making autonomous, AI-integrated academic discovery both innovative and responsible.
Molecular Devices. | 210B | Lars Kristiansen, Daniel Sipes, Mostafa ElSayed |
| 12:00 - 1:00 PM | Posters | A complete microbial workflow from plating and picking through growth curve measurement and plasmid DNA quantitation
Molecular Devices. | Exhibit Hall | Cathy Olsen |
| 12:00 - 1:00 PM | Posters | Automated Culture and Expansion of Patient-Derived Colorectal Cancer Organoids Using the CellXpress.ai System
Molecular Devices. | Exhibit Hall | Prathyushakrishna Macha |
| 2:00 - 3:00 PM | Posters | Automated development and disease modeling using iPSC-derived dorsal forebrain 3D organoids
Molecular Devices. | Exhibit Hall | Oksana Sirenko |
| 2:00 - 3:00 PM | Posters | Strategies for Rapid Intact Mass Screening Analysis: Achieving One-Second per Well
Genedata. | Exhibit Hall | Chelsea Nikula |
| 2:00 - 3:00 PM | Posters | An Integrated High-Throughput Workflow for Robust SPR-Based Biotherapeutic Characterization
Genedata. | Exhibit Hall | Ivana Serrano Lachapel |
| Time | Type | Description | Room / Location | Presenter |
| 12:00 - 1:00 PM | Posters | Label-Free Cell Imaging and Analysis Using Transmitted Light and Deep Learning
Molecular Devices. | Exhibit Hall | Prathyushakrishna Macha |
| 12:00- 1:00 PM | Posters | The development of a competitive SimpleStep ELISA for polyhistidine tag (His-Tag) using CaptSure technology
Abcam | Exhibit Hall | Moein Mohammadi |